Velocity Clinical Research, Inc.

In this month's edition, Craig Koch shares his vision as our new EVP, General Manager of Europe, leading Velocity's expansion across Germany, Poland, and the U.K. Also featured: • Velocity is a finalist for a 2025 Vaccine Industry Excellence Award • New case study: 2,750+ randomizations (125% of goal) across 29 sites • Brandon Essink, MD, CPI publishes next-gen flu vaccine study results in Vaccine • Our Hyderabad team celebrates a new office expansion Tap or click below to read The Recap! #ClinicalTrials #ClinicalResearch

We’ve come full circle! Alesia McFarlin, DNP, APRN, FNP-C, a Velocity Sub-Investigator in Anderson, SC, was recently selected as a 2025 ACRP Continuing Education Grant recipient, and will attend the upcoming #ACRP2025 Conference in New Orleans! ACRP educational grants and scholarships are supported in part by Ride4DEI. Last year, Rick Fisher was one of seven riders who completed the ride. To date, Ride4DEI has raised over $165,000. In Alesia’s words: "Many ask, ‘What’s the point and purpose of DEI?’ I can proudly share my story because of ACRP and Ride4DEI! I am honored to be supported by Rick and my Velocity family. I love what I do and look forward to working with an amazing team every day!" ACRP - Association of Clinical Research Professionals

It’s official! Thanks to your vote, Velocity is a finalist for the 2025 Vaccine Industry Excellence Award in the category of Best Clinical Trial Company. Winners will be announced on April 22 at the #WorldVaccineCongress in Washington, DC. Connect with our team ahead of the event to schedule time to discuss your next vaccine trial. Nicholas Campbell, Brandon Essink, MD, CPI, Nick Spittal, Christy Godwin, Jennifer Carl, Dan Robitaille, Paul Kergides #WVCDC #Vaccines #ClinicalTrials

Velocity has now been awarded more than 40 clinical trials involving 10 or more Velocity sites. Many of these studies include more than 25 sites, with one ongoing trial currently utilizing over 50 Velocity sites. Sponsors and CROs are increasingly partnering with Velocity to deliver significant portions, or even the entirety, of clinical trials. Learn more and explore recent case studies: https://lnkd.in/g7En6sbT #ClinicalResearch #ClinicalTrials #VelocityAtScale

Velocity is honored to once again sponsor #ClinicalTrialsDay, coming up on May 20. More to come soon!

Evelyne Mabouellet Newton, VP of Business Development, Europe, recently participated in a Clinical Operations Site Engagement Leader Roundtable, joining leaders in large pharma companies to discuss how to strengthen collaboration between research sites and Sponsors. Key attendees including heads of clinical operations and site engagement from leading pharmaceutical companies, with discussion focused on the growing challenges sites face — particularly increasing protocol complexity and fragmented technology solutions. The group explored strategies to enhance site engagement, reduce operational burden, and create more accessible pathways for new Principal Investigators and research sites. A special thank you to Veeva Systems for hosting this important conversation on improving site-Sponsor collaboration! These discussions are essential to ensuring research sites can help drive innovation and optimization in clinical development programs!

Our Hyderabad team had several reasons to celebrate over the past week! After settling into a new office space, the team marked International Women’s Day with heartfelt appreciation notes, recognizing the incredible contributions of women at Velocity and in the development of our VISION technology. Then, more than 20 teammates hit the pavement for the 5K Marathon for Sustainability Eco Run. It was a fantastic way to show gratitude, support a cause, and cross another finish line together. #IWD2025  #AccelerateAction

Luke Boylan, MBChB, MBA, Principal Investigator at Velocity in North London, recently attended the Parexel Site Alliance Network event. This collaborative gathering included NHS/NIHR-affiliated sites and other commercial research organizations, providing an invaluable opportunity to discuss the evolving landscape of clinical trials in the U.K. Dr. Boylan’s key takeaways from the event: • Regulatory Improvements: There was strong consensus from the MHRA on the need for faster regulatory approval timelines. There is a clear push to accelerate approvals and enhance the U.K.’s competitiveness within Europe. • Site Selection Insights: Sponsors are increasingly favoring sites with several years of operational experience before progressing beyond an initial 'introductory period.' • U.S./U.K. Competition: There is a growing trend of emulating U.S.-based approaches to site operations and recruitment. • Embracing Digital Platforms: Sponsors and CROs are increasingly seeing the value of sites and organizations that utilize centralized digital platforms for recruitment and data quality/collection. Technology is becoming a more pronounced differentiator for sites. • Fast Feasibility Responses: Prompt responses to feasibility and site selection questionnaires are crucial for commercial sites to stand out. • Remote Site Visits: Sites were encouraged to develop videos showcasing their facilities to support site qualification processes. This approach allows sponsors and patients to quickly assess capabilities, enhancing visibility and recruitment efforts. Additional discussions covered site selection, feasibility processes, investment trends, and site development initiatives from the NIHR. Key topics included private/public site integration and the use of mobile research units across the U.K. To learn more about Velocity’s capabilities in the U.K. and across Europe, connect with Evelyne Mabouellet Newton.

Velocity is seeking a Senior Analyst, Real-World Insight for our growing Business Intelligence team! Apply now: https://lnkd.in/ggdDV6kQ #NowHiring #BusinessIntelligence #ClinicalResearch #DataAnalysis #Pharma #Careers

Paul Evans sat down with Patricia Leuchten on the Leaders & Legends podcast, where they discussed the state of research sites and the broader industry. Listen now to hear Paul's thoughts on:  • The evolution of clinical research sites and what’s ahead for the industry.  • Challenges in patient recruitment and the role of site-based technology.  • His journey from growing up in Swansea, Wales, to leading the world’s largest research site organization. Spotify: https://lnkd.in/gRsF4734 Apple Podcasts: https://lnkd.in/gpZMEk83 #ClinicalResearch #ClinicalTrials #Podcast